BACKGROUND: Alzheimer's Disease (AD) is an irreversible neurodegenerative disorder that imposes a significant burden on families and society. Timely intervention during the transitional stages from Mild Cognitive Impairment (MCI) to AD can help mitigate this issue. The MCI-to-AD conversion time would be helpful if it could be predicted. Most studies rely on Cox models, which possess certain limitations and do not intuitively forecast the duration until patients with MCI progress to AD. Thus we construct a new dynamic prediction model based on the conditional restricted mean survival time (cRMST) from a time-scale perspective to explore the factors influencing progression to AD in patients with MCI and predict the average time required MCI patients to progress to AD at different time points in the future. METHODS: We construct a new two-stage dynamic prediction model (tRMST model) based on the conditional restricted mean survival time (cRMST) in combination with landmark method to apply in the analysis of the ADNI database. RESULTS: The results of the ADNI analysis showed that four variables (Education, MMSE, ADAS-Cog13 and P-tau) have dynamic effects over time. The C-index and the mean prediction error of the cross validation are better than the static RMST model. CONCLUSION: This study presents a time-scale dynamic prediction model that effectively leverages longitudinal data to identify the dynamic effects of the factors' impact on the outcome over time, thereby assisting physicians in personalizing treatment for patients.
A dynamic prediction model for predicting the time at which patients with MCI progress to AD based on time-dependent covariates.
阅读:6
作者:Wang Yanjie, Song Yu, Zhang Chengfeng, Ren Jiaqiao, Xue Pansheng, Hou Yawen, Chen Zheng
| 期刊: | BMC Medical Informatics and Decision Making | 影响因子: | 3.800 |
| 时间: | 2025 | 起止号: | 2025 Jul 1; 25(1):226 |
| doi: | 10.1186/s12911-025-03040-5 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
